Literature DB >> 9923759

Diagnostic criteria for Parkinson disease.

D J Gelb1, E Oliver, S Gilman.   

Abstract

The clinical diagnosis of Parkinson disease (PD) is based on the identification of some combination of the cardinal motor signs of bradykinesia, rigidity, tremor, and postural instability, but few attempts have been made to develop explicit diagnostic criteria. We propose a clinical diagnostic classification based on a comprehensive review of the literature regarding the sensitivity and specificity of the characteristic clinical features of PD. Three levels of diagnostic confidence are differentiated: Definite, Probable, and Possible. The diagnoses of Possible and Probable PD are based on clinical criteria alone. Neuropathologic confirmation is required for the diagnosis of Definite PD in patients with the clinical diagnosis of Possible or Probable PD. Criteria for histopathologic confirmation of PD are also presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9923759     DOI: 10.1001/archneur.56.1.33

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  792 in total

1.  Progressive dementia and gait disorder in a 78 year old woman.

Authors:  M Tagliati; D P Perl; B Drayer; C W Olanow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

2.  Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease.

Authors:  D E Riley; T C Chelimsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

3.  DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function.

Authors:  Ling-Yang Hao; Benoit I Giasson; Nancy M Bonini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

4.  Autopsy consent, brain collection, and standardized neuropathologic assessment of ADNI participants: the essential role of the neuropathology core.

Authors:  Nigel J Cairns; Lisa Taylor-Reinwald; John C Morris
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

5.  Transcranial sonography on Parkinson's disease and essential tremor in a Chinese population.

Authors:  Wei-Feng Luo; Ying-Chun Zhang; Yu-Jing Sheng; Jun-Chu Fang; Chun-Feng Liu
Journal:  Neurol Sci       Date:  2011-12-11       Impact factor: 3.307

6.  Transcranial sonography image characteristics in different Parkinson's disease subtypes.

Authors:  Ai Yan Sheng; Ying Chun Zhang; Yu Jing Sheng; Cai Shan Wang; Ying Zhang; Hua Hu; Wei Feng Luo; CHun-Feng LIu
Journal:  Neurol Sci       Date:  2017-07-19       Impact factor: 3.307

7.  Parkinson's Disease-Related Motor and Nonmotor Symptoms in the Lancaster Amish.

Authors:  Michael D F Goldenberg; Xuemei Huang; Honglei Chen; Lan Kong; Teodor T Postolache; John W Stiller; Katherine A Ryan; Mary Pavlovich; Toni I Pollin; Alan R Shuldiner; Richard B Mailman; Braxton D Mitchell
Journal:  Neuroepidemiology       Date:  2020-07-31       Impact factor: 3.282

8.  Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.

Authors:  Sarra Nazem; Andrew D Siderowf; John E Duda; Tom Ten Have; Amy Colcher; Stacy S Horn; Paul J Moberg; Jayne R Wilkinson; Howard I Hurtig; Matthew B Stern; Daniel Weintraub
Journal:  J Am Geriatr Soc       Date:  2008-12-10       Impact factor: 5.562

9.  Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson's disease patients as assessed by the Non-Motor Symptoms Questionnaire.

Authors:  David Crosiers; Barbara Pickut; Jessie Theuns; Peter Paul De Deyn; Christine Van Broeckhoven; Pablo Martinez-Martin; K Ray Chaudhuri; Patrick Cras
Journal:  Am J Neurodegener Dis       Date:  2012-07-23

10.  'Gamma' band oscillatory response to chromatic stimuli in volunteers and patients with idiopathic Parkinson's disease.

Authors:  Walter G Sannita; Simone Carozzo; Paolo Orsini; Luciano Domenici; Vittorio Porciatti; Mauro Fioretto; Sergio Garbarino; Ferdinando Sartucci
Journal:  Vision Res       Date:  2009-02-14       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.